Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children

Yi-Chen Lee1, Chih-Hao Chang2, Wei-Ju Lee3

  • 1Department of Pediatrics, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Kaohsiung, Taiwan; Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taiwan.

Abstract

Insights

Children with Mycoplasma pneumoniae pneumonia (MPP) show altered chemokine profiles. Refractory MPP (RMPP) exhibits distinct chemokine patterns compared to non-refractory MPP (NRMPP), indicating unique inflammatory responses.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae pneumonia (MPP) is a common childhood respiratory infection.
  • While often self-limiting, MPP can lead to severe complications and is associated with macrophage activation and cytokine release.
  • Refractory MPP (RMPP) signifies clinical deterioration despite antibiotics, often linked to excessive inflammation requiring glucocorticoids.

Purpose of the Study:

  • To analyze changes in plasma chemokines in children with non-refractory MPP (NRMPP) and RMPP.
  • To compare chemokine profiles before and after treatment with antibiotics or methylprednisolone.

Main Methods:

  • Plasma samples were collected from 42 children with MPP at admission and post-treatment.
  • Chemokine levels were measured using plasma specimens.
  • Patients were categorized into RMPP and NRMPP groups for comparative analysis.

Main Results:

  • MPP infection altered chemokine profiles, showing decreased M1-related chemokines (CCL2, CCL8, CXCL10) and increased M2-related chemokines (CCL17, CCL22) post-treatment.
  • Before treatment, RMPP patients had higher CXCL10 and lower CCL3 and CCL11 levels compared to NRMPP patients.
  • These findings highlight distinct chemokine signatures between RMPP and NRMPP.

Conclusions:

  • Macrophage-related chemokines exhibit unique changes during MPP infection.
  • Distinct chemokine profiles differentiate NRMPP from RMPP in children.
  • Chemokine analysis may aid in understanding and managing MPP severity.